Suchergebnisse - Kevin D. Dieckhaus
- Treffer 1 - 6 von 6
-
1
-
2
Home Visits to Improve Adherence to Highly Active Antiretroviral Therapy von Ann B. Williams, Kristopher P. Fennie, Carol Bova, Jane Burgess, Karina Danvers, Kevin D. Dieckhaus
Veröffentlicht 2006Artigo -
3
Cue-dose training with monetary reinforcement von Michael O. Rigsby, Marc I. Rosen, John Beauvais, Joyce A. Cramer, Petrie M. Rainey, Stephanie S. O’Malley, Kevin D. Dieckhaus, Bruce J. Rounsaville
Veröffentlicht 2000Artigo -
4
Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use von Thuy Le, Jennifer Chiarella, Birgitte B. Simen, Bozena Hanczaruk, Michael D. Miller, Marie L. Landry, Kevin D. Dieckhaus, Marc I. Rosen, Michael J. Kozal
Veröffentlicht 2009Artigo -
5
Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection von Jie Yang, Yang Song, Xiangyu Deng, Jeffrey A. Vanegas, Zheng You, Yuxuan Zhang, Zhengyan Weng, Lori Avery, Kevin D. Dieckhaus, Advaith Peddi, Yang Gao, Yi Zhang, Xue Gao
Veröffentlicht 2022Artigo -
6
Amplification‐Free Detection of SARS‐CoV‐2 and Respiratory Syncytial Virus Using CRISPR Cas13a and Graphene Field‐Effect Transistors von Huijie Li, Jie Yang, Guangfu Wu, Zhengyan Weng, Yang Song, Yuxuan Zhang, Jeffrey A. Vanegas, Lori Avery, Zan Gao, He Sun, Yupeng Chen, Kevin D. Dieckhaus, Xue Gao, Yi Zhang
Veröffentlicht 2022Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Biology
Internal medicine
Physical therapy
Psychiatry
Randomized controlled trial
Computational biology
Genetics
Intervention (counseling)
Nucleic acid
Psychological intervention
Psychology
Virology
Abstinence
Abundance (ecology)
Antiretroviral drug
Antiretroviral therapy
Attendance
Biochemistry
Business
CRISPR
Chemistry
Clinical psychology
Cohort
Collateral
Collateral damage
Contingency management
Criminology
Drug
Drug resistance